Moreover in pancreatic cancer cells TGFβ treatment caused an epithelial-mesenchymal transition that was associated with a more invasive phenotype and with the activation of ERK-signaling cascade[54]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.